Eight Domestic Companies Secure Provisional Selection in China's 9th National Drug Procurement for Atomoxetine Oral Solution; Eli Lilly Misses Out

Reporters learned at the opening ceremony of the ninth batch of national procurement in China that the tentative winning results for the variety with the most competing companies, atomoxetine hydrochloride oral solution, have been released. A total of eight companies are tentatively selected in order: Anhui Xinshiji Pharmaceutical Co., Ltd., Guangxi Weiwei Pharmaceutical Co., Ltd., Changchun Lanjiang Pharmaceutical Technology Co., Ltd., Hubei Jinluo Silk Cloth Co., Ltd., Shandong Daoqi Biomedical Technology Co., Ltd., Beimei Pharma, Jiangsu Guangcheng Pharmaceutical Co., Ltd., and Zhejiang Bai'ao Pharmaceutical Co., Ltd. The original research company, Eli Lilly and Company, was not among the winners. (Cailian Press)Original Link